Changes in actin dynamics and F-actin structure both in synaptoneurosomes of LRRK2(R1441G) mutant mice and in primary human fibroblasts of LRRK2(G2019S) mutation carriers

Neuroscience. 2015 Jan 22:284:311-324. doi: 10.1016/j.neuroscience.2014.09.070. Epub 2014 Oct 6.

Abstract

Converging evidence suggests that the Parkinson's disease-linked leucine-rich repeat kinase 2 (LRRK2) modulates cellular function by regulating actin dynamics. In the present study we investigate the role of LRRK2 in functional synaptic terminals of adult LRRK2-knockout and LRRK2(R1441G)-transgenic mice as well as in primary fibroblasts of LRRK2(G2019S) mutation carriers. We show that lack of LRRK2 decreases and overexpression of mutant LRRK2 age-dependently increases the effect of the actin depolymerizing agent Latrunculin A (LatA) on the synaptic cytoskeleton. Similarly, endogenous mutant LRRK2 increases sensitivity to LatA in primary fibroblasts. Under basal conditions however, these fibroblasts show an increase in F-actin bundles and a decrease in filopodial length which can be rescued by LatA treatment. Our data suggest that LRRK2 alters actin dynamics and F-actin structure both in brain neurons and skin fibroblasts. We hypothesize that increased F-actin bundling represents a compensatory mechanism to protect F-actin from the depolymerizing effect of mutant LRRK2 under basal conditions. Our data further indicate that LRRK2-dependent changes in the cytoskeleton might have functional consequences on postsynaptic NMDA receptor localization.

Keywords: F-actin; LRRK2; Parkinson’s disease; fibroblasts; filopodia; synaptoneurosomes.

MeSH terms

  • Actins / metabolism*
  • Aging / metabolism
  • Animals
  • Bridged Bicyclo Compounds, Heterocyclic / pharmacology
  • Cells, Cultured
  • Central Nervous System Agents / pharmacology
  • Fibroblasts / cytology
  • Fibroblasts / metabolism
  • Humans
  • Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Mice, Transgenic
  • Phosphatidylserines / metabolism
  • Presynaptic Terminals / metabolism*
  • Presynaptic Terminals / ultrastructure
  • Protein Serine-Threonine Kinases / genetics
  • Protein Serine-Threonine Kinases / metabolism*
  • Pseudopodia / metabolism
  • Pseudopodia / ultrastructure
  • Receptors, N-Methyl-D-Aspartate / metabolism
  • Synaptosomes / metabolism*
  • Synaptosomes / ultrastructure
  • Thiazolidines / pharmacology

Substances

  • Actins
  • Bridged Bicyclo Compounds, Heterocyclic
  • Central Nervous System Agents
  • Phosphatidylserines
  • Receptors, N-Methyl-D-Aspartate
  • Thiazolidines
  • LRRK2 protein, human
  • Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
  • Lrrk2 protein, mouse
  • Protein Serine-Threonine Kinases
  • latrunculin A
  • N-methyl D-aspartate receptor subtype 2A